Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
about
Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteinsThe crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemiaGenetically modified mouse models for the study of nonalcoholic fatty liver diseaseGenetics of lipid traits and relationship to coronary artery diseaseExpression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditionsDefective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient miceLiver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levelsAspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet.Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly.Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden miceLipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.Hepatic ABCA1 and VLDL triglyceride production.Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCellsAnacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates.Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: the Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan.ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyEffect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboEffect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With LipodystrophyDiffering rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol.Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.Antisense technology: an emerging platform for cardiovascular disease therapeutics.Development of Antisense Drugs for Dyslipidemia.Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases.ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helixFoxo1 mediates insulin action on apoC-III and triglyceride metabolism.ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure.Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion.Brown adipose tissue takes up plasma triglycerides mostly after lipolysisThe peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E.Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
P2860
Q24651503-A195F3C1-14FA-42D6-AB30-983527DE01A6Q26864682-7EB36A0B-F714-44C3-A3A1-56A72EBF31D3Q26865248-D46F2409-2930-44E2-B9F6-ED76FC0A5425Q26995252-10B84B87-04A7-4698-A56F-4257B2F996D6Q28252652-27A0D474-E432-4ED4-8B47-7B6410CB568AQ33697550-52BA6D31-82C6-4A64-A893-765818511189Q33958622-F9E6596E-5429-47A0-BCF6-5FCD969EA2C4Q33976115-C8ADA153-8C82-4F2C-B79C-B74CE5B986DDQ34382248-0159ECE8-AB7D-4D44-BF22-8071472649EAQ34466387-0DAA7362-268A-4A3B-BFEE-F0CA966DB47DQ34776315-36B2530C-28CC-41D7-A092-D8BCCE69F017Q35546434-A7CED45A-5650-4574-8E11-A4204A4F8124Q35737630-2331682E-E94A-4876-B4E3-BE3BC88E6B66Q35776630-BB649F69-1C08-447A-AF69-FE5DE3BD1FB0Q36056470-5B6869DB-9CB6-4CAA-A551-8AEFFF912403Q36197815-3FEE855D-E71D-45F7-AE71-D823ADDD9B40Q36401998-2DB0C0B1-5B26-4049-A959-CAD9A15E7EFCQ36527075-BE1A54B4-3EBF-4906-8698-0CEE7C73B732Q36558367-F1991964-DA67-4CFC-8FDC-E823BEED90A4Q36577724-48B6B8D4-9D66-4D80-9D85-AE06AEF575BBQ36935534-50F074ED-72F6-44D5-AF0C-711D8B73B1B8Q37076522-F6DFAB1D-ED08-4DEE-B405-6332EC650BDFQ37078689-102C275D-146F-485A-9D57-F1C1DF4C97B6Q37337608-B335814B-CC1A-4291-8F92-D72340DCD2E8Q37387192-E8CBDA7C-7B4E-4AC9-8A18-76C4BDCA6F3AQ37709764-399DD9EA-63E6-43B9-ABA6-177C5C670F51Q39614082-5486FFFE-0475-4429-B360-F57E3283341EQ39723291-B19C8D42-D6F1-427C-8042-FDE097CEC389Q40301333-F259EF5B-E6DB-4FCA-8C12-AF460025CDF2Q40420953-2CC40997-3CCE-4E80-BD76-3B6F26752018Q41585297-DAB3A728-8524-4E5A-951F-8FFFB7000D3AQ42097167-F5C1C0FD-5481-4A90-AB5C-A97748A51F65Q43003001-E50720BA-2B75-4CE8-8111-24891CEA45A3Q50183430-5368B0F2-D057-43D3-920D-9B8544CA88DEQ51172839-AE333CA3-2A3D-4A92-947D-6F31037A86C9
P2860
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
description
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Oktober 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/10/01)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/10/01)
@nl
наукова стаття, опублікована в жовтні 2001
@uk
مقالة علمية (نشرت في أكتوبر 2001)
@ar
name
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@ast
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@en
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@nl
type
label
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@ast
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@en
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@nl
prefLabel
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@ast
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@en
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@nl
P2093
P921
P3181
P1476
Apolipoprotein C-III deficienc ...... ld-type and apoE knockout mice
@en
P2093
Dahlmans VE
Havekes LM
van Berkel TJ
van der Boom H
P304
P3181
P577
2001-10-01T00:00:00Z